Guard Therapeutics International AB (publ) (STO:GUARD)

Sweden flag Sweden · Delayed Price · Currency is SEK
1.750
+0.095 (5.74%)
Feb 11, 2026, 10:34 AM CET
Market Cap33.38M -87.5%
Revenue (ttm)n/a
Net Income-118.48M
EPS-7.38
Shares Out20.17M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,672
Average Volume66,920
Open1.690
Previous Close1.655
Day's Range1.690 - 1.935
52-Week Range1.100 - 32.800
Beta-0.20
RSI39.82
Earnings DateFeb 20, 2026

About STO:GUARD

Guard Therapeutics International AB (publ), a clinical-stage biotechnology company, identifies and develops medicines to treat kidney diseases in Sweden. Its pipeline products include RMC-035, an intact therapeutic A1M protein, that is in Phase 2b clinical trial for kidney protection with open-heart surgery; in Phase 2a clinical trial for kidney transplantation; and is in preclinical trial to treat Sepsis. It also develops GTZ peptides, a modified A1M-derived peptides, that is in preclinical studies for the treatment of CKD and diabetes, heart ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2008
Employees 12
Stock Exchange Nasdaq Stockholm
Ticker Symbol GUARD
Full Company Profile

Financial Performance

Financial Statements